| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 26/12/2018 | 14h01 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 26/12/2018 | 12h01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 22h04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 21h54 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 15h20 | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 15h17 | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 15h13 | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 15h09 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 14h25 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 14h24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 13/12/2018 | 14h20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |